In the BioHarmony Drug Report Database

"Preview" Icon

Treosulfan

Trecondi (treosulfan) is a small molecule pharmaceutical. Treosulfan was first approved as Trecondi on 2019-06-20. It has been approved in Europe to treat hematopoietic stem cell transplantation.

 

Trade Name

 

Trecondi
 

Common Name

 

treosulfan
 

ChEMBL ID

 

CHEMBL455186
 

Indication

 

hematopoietic stem cell transplantation
 

Drug Class

 

Antineoplastics, alkylating agents (methanesulfonate derivatives)

Image (chem structure or protein)

Treosulfan structure rendering